New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 25, 2013
09:26 EDTCYTXCytori Therapeutics receives CE Mark in Europe for Intravase
Cytori Therapeutics has received a CE Mark in Europe for Intravase, a reagent intended to be used with Cytori’s Celution System for preparing safe and optimized adipose-derived stem and regenerative cells for intravascular delivery into the same patient.
News For CYTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 24, 2014
15:34 EDTCYTXCytori Therapeutics restructuring, new alignment positive, says Maxim
Subscribe for More Information
September 22, 2014
08:12 EDTCYTXCytori sees 'modest overall revenue growth' in FY14
The company said, "Despite the impact of the cost reduction efforts, Cytori continues to anticipate modest overall revenue growth in 2014. Overall revenue growth in 2015 and 2016 will likely continue to be modest but should show a positive contribution margin beginning in 2015 based on the combination of recent expense reductions and forecasted increases in sales to Lorem Vascular and other partners, as well as through Cytori’s leaner direct sales teams in both Japan and Europe." FY14 revenue consensus $15.06M.
08:05 EDTCYTXCytori announces restructuring, cost reduction plans
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use